Vimarsana
Biggest News Aggregation in the World

Vorpacept News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vorpacept . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vorpacept Today - Breaking & Trending Today

ALX Oncology More Than Doubles In Pre-market After Positive Interim Phase 2 Data From ASPEN-06 Trial - Vimarsana News

ALX Oncology More Than Doubles In Pre-market After Positive Interim Phase 2 Data From ASPEN-06 Trial

Shares of ALX Oncology Holdings Inc. (ALXO) were trading up over 114 percent on Tuesday after the company reported positive prespecified interim Phase 2 data from its ASPEN-06 clinical trial of Evorpacept for Cancer.

ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer - Vimarsana News

ALX Oncology Reports Positive Interim Phase 2 Data From ASPEN-06 Trial Of Evorpacept For Cancer

Immuno-oncology company ALX Oncology Holdings Inc. (ALXO) announced Tuesday positive prespecified interim Phase 2 data from its ASPEN-06 clinical trial, a randomized multi-center international study evaluating evorpacept, the Company's CD47 blocking therapeutic, in combination with trastuzumab, CYRAMZA (ramucirumab) and paclitaxel for the treatment of patients with HER2-positive gastric/gastroesophageal junction (GEJ) cancer.